we are pioneering the development of T-cell based vaccines for major infectious diseases | including hepatitis C |
融资轮次 | 融资日期 | 投资方 | 融资额度 |
---|---|---|---|
A轮 | 2007-03 | BioMedPartner、Life Sciences Partners | $7.2M |
A轮 | 2007-03 | BioMedPartners、Life Sciences Partners | $7.2M |
B轮 | 2010-09 | Boehringer Ingelheim Venture Fund、Versant Ventures | $20.5M |
B轮 | 2010-09 | Boehringer Ingelheim Venture Fund、Versant Ventures | $20.5M |